Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 2—February 2023
Research Letter

Nocardia neocaledoniensis as Rare Cause of Spondylodiscitis

Emeline Choquet, Veronica Rodriguez-Nava, François Peltier, Rodrigue Wankap-Mogo, Emmanuelle Bergeron, Cédric Joseph, and Nadine LemaitreComments to Author 
Author affiliations: Centre Hospitalier Universitaire, Amiens, France (E. Choquet, F. Peltier, R. Wankap-Mogo, C. Joseph, N. Lemaitre); Université Lyon 1, Lyon, France (V. Rodriguez-Nava, E. Bergeron).

Main Article

Table

Antimicrobial susceptibility of Nocardia neocalendoniensis interpreted according to Clinical and Laboratory Standards Institute breakpoints (7)*

Antimicrobial MIC, mg/L Susceptibility
Amoxicillin/clavulanic acid >64/32 R
Ceftriaxone 4 S
Imipenem 4 S
Amikacin <1 S
Tobramycin <1 S
Linezolid 2 S
Trimethoprim/sulfamethoxazole 0.5/9.5 S
Minocycline 4 I
Doxycycline 8 R
Ciprofloxacin >4 R
Moxifloxacin 2 I
Clarithromycin 16 R

*I, intermediate; R, resistant; S, susceptible.

Main Article

References
  1. Schoch  CL, Ciufo  S, Domrachev  M, Hotton  CL, Kannan  S, Khovanskaya  R, et al. NCBI taxonomy: a comprehensive update on curation, resources and tools. Database (Oxford). 2020;2020:baaa062.
  2. Mehta  HH, Shamoo  Y. Pathogenic Nocardia: A diverse genus of emerging pathogens or just poorly recognized? PLoS Pathog. 2020;16:e1008280. DOIPubMedGoogle Scholar
  3. Saintpierre-Bonaccio  D, Maldonado  LA, Amir  H, Pineau  R, Goodfellow  M. Nocardia neocaledoniensis sp. nov., a novel actinomycete isolated from a New-Caledonian brown hypermagnesian ultramafic soil. Int J Syst Evol Microbiol. 2004;54:599–603. DOIPubMedGoogle Scholar
  4. McGhie  T, Fader  R, Carpenter  J, Brown-Elliott  BA, Vasireddy  R, Wallace  RJ Jr. Nocardia neocaledoniensis [corrected] as a cause of skin and soft tissue infection. J Clin Microbiol. 2012;50:3139–40. DOIPubMedGoogle Scholar
  5. Hazarika  K, Sahoo  RR, Ekbote  D, Dixit  AK, Marak  RS, Wakhlu  A. Multidrug-resistant novel Nocardia neocaledoniensis brain abscess in sarcoidosis. BMJ Case Rep. 2021;14:e240123. DOIPubMedGoogle Scholar
  6. Regueme  A, Vachee  A, Duployez  C, Petit  AE, Coulon  P, Wallet  F, et al. First case of fatal bacteremia due to Nocardia neocaledoniensis. IDCases. 2020;22:e00934. DOIPubMedGoogle Scholar
  7. Conville  PS, Brown-Elliott  BA, Smith  T, Zelazny  AM. The complexities of Nocardia taxonomy and identification. J Clin Microbiol. 2017;56:e01419–17.PubMedGoogle Scholar
  8. Sánchez-Herrera  K, Sandoval  H, Mouniee  D, Ramírez-Durán  N, Bergeron  E, Boiron  P, et al. Molecular identification of Nocardia species using the sodA gene: Identificación molecular de especies de Nocardia utilizando el gen sodA. New Microbes New Infect. 2017;19:96–116. DOIPubMedGoogle Scholar
  9. Marín  M, Ruiz  A, Iglesias  C, Quiroga  L, Cercenado  E, Martín-Rabadán  P, et al. Identification of Nocardia species from clinical isolates using MALDI-TOF mass spectrometry. Clin Microbiol Infect. 2018;24:1342.e5–8. DOIPubMedGoogle Scholar
  10. Durand  T, Vautrin  F, Bergeron  E, Girard  V, Polsinelli  S, Monnin  V, et al. Assessment of VITEK® MS IVD database V3.0 for identification of Nocardia spp. using two culture media and comparing direct smear and protein extraction procedures. Eur J Clin Microbiol Infect Dis. 2020;39:559–67. DOIPubMedGoogle Scholar

Main Article

Page created: December 20, 2022
Page updated: January 21, 2023
Page reviewed: January 21, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external